Abstract
Purpose
Pulmonary metastasis was a negative factor of osteosarcoma prognosis. However, there is no universal criteria to confirm pulmonary metastasis at pulmonary micro nodule (PMN, Dmax ≤ 5 mm) stage other than pathology. We aimed to identify prevalence of PMNs, determine prognosis of osteosarcoma with PMNs, and analyze risk factors related to PMN progression.
Methods
We retrospectively reviewed 425 consecutive osteosarcoma patients. According to dynamic change in size and number of PMNs, patients were divided into PMN progression and non-progression group. Demographic data, initial laboratory data, radiological features, and oncological evaluations were analyzed. Cox regression was used to identify risk factors for PMN progression. Overall survival rate was measured and analyzed with Kaplan–Meier method. Differences with p < 0.05 were considered significant.
Results
PMNs were found in 74% (315/425) osteosarcoma patients, half of whom (157/315) suffering PMN progression. Overall survival rate was 70.2%, while survival rates for PMN progression group and non-progression group were 53.40% and 87.40%, respectively. Clinical risk factors for PMN progression in certain patients included blood vessel invasion, extrapulmonary metastases, low tumour cell necrosis rate, and large tumour size. Radiologic risk factors included greatest diameter, distance to pleura, CT value, solid components, and smooth border.
Conclusion
PMN is quite common in osteosarcoma patients. PMN progression is related to both certain clinical and radiological factors, which could assist surgeons to determine its possibility to progress at an early stage.
Similar content being viewed by others
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H, Winkler K (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776–790. https://doi.org/10.1200/JCO.2002.20.3.776
Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N (2012) Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children’s Oncology Group. Cancer 118:4597–4605. https://doi.org/10.1002/cncr.27414
Ogura K, Fujiwara T, Yasunaga H, Matsui H, Jeon DG, Cho WH, Hiraga H, Ishii T, Yonemoto T, Kamoda H, Ozaki T, Kozawa E, Nishida Y, Morioka H, Hiruma T, Kakunaga S, Ueda T, Tsuda Y, Kawano H, Kawai A (2015) Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: a multi-institutional study. Cancer 121:3844–3852. https://doi.org/10.1002/cncr.29575
Picci P, Mercuri M, Ferrari S, Alberghini M, Briccoli A, Ferrari C, Pignotti E, Bacci G (2010) Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol 21:1366–1373. https://doi.org/10.1093/annonc/mdp502
Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kuhne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N (2019) Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer 109:36–50. https://doi.org/10.1016/j.ejca.2018.11.027
Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M, EURAMOS collaborators (2015) EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Ann Oncol 26(2):407–14. https://doi.org/10.1093/annonc/mdu526
Tsoi KM, Lowe M, Tsuda Y, Lex JR, Fujiwara T, Almeer G, Gregory J, Stevenson J, Evans SE, Botchu R, Jeys LM (2021) How are indeterminate pulmonary nodules at diagnosis associated with survival in patients with high-grade osteosarcoma? Clin Orthop Relat Res 479:298–308. https://doi.org/10.1097/CORR.0000000000001491
Mayo Z, Kennedy S, Gao Y, Miller BJ (2019) What Is the clinical importance of incidental findings on staging CT scans in patients with sarcoma? Clin Orthop Relat Res 477:730–737. https://doi.org/10.1007/s11999.0000000000000149
McLoughlin E, Davies AM, Iqbal A, James SL, Botchu R (2020) The diagnostic significance of pulmonary nodules on CT thorax in chondrosarcoma of bone. Clin Radiol 75:395.e397-395.e316. https://doi.org/10.1016/j.crad.2019.11.017
Seher K, Saeed H, Kareem T, Baqari AS, Niazi I, Wali RM (2021) Indeterminate pulmonary nodules in osteosarcoma are associated with increased risk of pulmonary metastasis. J Pediatr Hematol Oncol 43:e826–e831. https://doi.org/10.1097/MPH.0000000000002124
Kusma J, Young C, Yin H, Stanek JR, Yeager N, Aldrink JH (2017) Pulmonary nodule size <5 mm still warrants investigation in patients with osteosarcoma and Ewing sarcoma. J Pediatr Hematol Oncol 39:184–187. https://doi.org/10.1097/MPH.0000000000000753
Davison R, Hamati F, Kent P (2021) What effect do pulmonary micronodules detected at presentation in patients with osteosarcoma have on 5-year overall survival? J Clin Med 10. https://doi.org/10.3390/jcm10061213
Cho YJ, Kim WS, Choi YH, Ha JY, Lee S, Park SJ, Cheon JE, Kang HJ, Shin HY, Kim IO (2019) Computerized texture analysis of pulmonary nodules in pediatric patients with osteosarcoma: differentiation of pulmonary metastases from non-metastatic nodules. PLoS ONE 14:e0211969. https://doi.org/10.1371/journal.pone.0211969
Gross BH, Glazer GM, Bookstein FL (1985) Multiple pulmonary nodules detected by computed tomography: diagnostic implications. J Comput Assist Tomogr 9:880–885. https://doi.org/10.1097/00004728-198509000-00007
Ciccarese F, Bazzocchi A, Ciminari R, Righi A, Rocca M, Rimondi E, Picci P, Bacchi Reggiani ML, Albisinni U, Zompatori M, Vanel D (2015) The many faces of pulmonary metastases of osteosarcoma: retrospective study on 283 lesions submitted to surgery. Eur J Radiol 84:2679–2685. https://doi.org/10.1016/j.ejrad.2015.09.022
Fernandez-Pineda I, Daw NC, McCarville B, Emanus LJ, Rao BN, Davidoff AM, Shochat SJ (2012) Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experience. J Pediatr Surg 47:1250–1254. https://doi.org/10.1016/j.jpedsurg.2012.03.033
Saifuddin A, Baig MS, Dalal P, Strauss SJ (2021) The diagnosis of pulmonary metastases on chest computed tomography in primary bone sarcoma and musculoskeletal soft tissue sarcoma. Br J Radiol 94:20210088. https://doi.org/10.1259/bjr.20210088
Murrell Z, Dasgupta R (2013) What predicts the risk of recurrent lung metastases? J Pediatr Surg 48:1020–1024. https://doi.org/10.1016/j.jpedsurg.2013.02.018
Buddingh EP, Anninga JK, Versteegh MI, Taminiau AH, Egeler RM, van Rijswijk CS, Hogendoorn PC, Lankester AC, Gelderblom H (2010) Prognostic factors in pulmonary metastasized high-grade osteosarcoma. Pediatr Blood Cancer 54:216–221. https://doi.org/10.1002/pbc.22293
Aljubran AH, Griffin A, Pintilie M, Blackstein M (2009) Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol 20:1136–1141. https://doi.org/10.1093/annonc/mdn731
Ghosh KM, Lee LH, Beckingsale TB, Gerrand CH, Rankin KS (2018) Indeterminate nodules in osteosarcoma: what’s the follow-up? Br J Cancer 118:634–638. https://doi.org/10.1038/bjc.2017.453
Rissing S, Rougraff BT, Davis K (2007) Indeterminate pulmonary nodules in patients with sarcoma affect survival. Clin Orthop Relat Res 459:118–121. https://doi.org/10.1097/BLO.0b013e31805d8606
Absalon MJ, McCarville MB, Liu T, Santana VM, Daw NC, Navid F (2008) Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma. Pediatr Blood Cancer 50:1147–1153. https://doi.org/10.1002/pbc.21454
Richardson K, Potter M, Damron TA (2016) Image intensive soft tissue sarcoma surveillance uncovers pathology earlier than patient complaints but with frequent initially indeterminate lesions. J Surg Oncol 113:818–822. https://doi.org/10.1002/jso.24230
Roxburgh CS, McMillan DC, Anderson JH, McKee RF, Horgan PG, Foulis AK (2010) Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann Surg 252:989–997. https://doi.org/10.1097/SLA.0b013e3181f1c60d
Mohammed RA, Ellis IO, Mahmmod AM, Hawkes EC, Green AR, Rakha EA, Martin SG (2011) Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance. Mod Pathol 24:774–785. https://doi.org/10.1038/modpathol.2011.4
Kim JH, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, Lee JH, Kim YS (2010) Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer. J Surg Res 162:177–183. https://doi.org/10.1016/j.jss.2009.07.015
Liang H, Guo W, Tang X, Yang R, Yan T, Yang Y, Ji T, Sun X, Xie L, Xu J (2021) Venous tumor thrombus in primary bone sarcomas in the pelvis: a clinical and radiographic study of 451 Cases. J Bone Joint Surg Am 103:1510–1520. https://doi.org/10.2106/JBJS.20.00569
Bedi M, King DM, Charlson J, Whitfield R, Hackbarth DA, Zambrano EV, Wang D (2014) Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival. Am J Clin Oncol 37:272–277. https://doi.org/10.1097/COC.0b013e318277d7e5
Bacci G, Longhi A, Bertoni F, Briccoli A, Versari M, Pignotti E, Picci P (2006) Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients. Acta Orthop 77:938–943. https://doi.org/10.1080/17453670610013268
Hong Z, England P, Rhea L, Hirbe A, McDonald D, Cipriano CA (2021) Patterns of extrapulmonary metastases in sarcoma surveillance. Cancers (Basel). 13. https://doi.org/10.3390/cancers13184669
Bacci G, Bertoni F, Longhi A, Ferrari S, Forni C, Biagini R, Bacchini P, Donati D, Manfrini M, Bernini G, Lari S (2003) Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 97:3068–3075. https://doi.org/10.1002/cncr.11456
Nathan SS, Gorlick R, Bukata S, Chou A, Morris CD, Boland PJ, Huvos AG, Meyers PA, Healey JH (2006) Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis. Cancer 107:1607–1616. https://doi.org/10.1002/cncr.22197
Guenther LM, Rowe RG, Acharya PT, Swenson DW, Meyer SC, Clinton CM, Guo D, Sridharan M, London WB, Grier HE, Ecklund K, Janeway KA (2018) Response evaluation criteria in solid tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma. Pediatr Blood Cancer 65. https://doi.org/10.1002/pbc.26896
Ward WG, Mikaelian K, Dorey F, Mirra JM, Sassoon A, Holmes EC, Eilber FR, Eckardt JJ (1994) Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 12:1849–1858. https://doi.org/10.1200/JCO.1994.12.9.1849
Li X, Ashana AO, Moretti VM, Lackman RD (2011) The relation of tumour necrosis and survival in patients with osteosarcoma. Int Orthop 35:1847–1853. https://doi.org/10.1007/s00264-011-1209-7
Xie L, Huang W, Wang H, Zheng C, Jiang J (2020) Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study. J Orthop Surg Res 15:32. https://doi.org/10.1186/s13018-020-1571-5
Basile P, Greengard E, Weigel B, Spector L (2020) Prognostic factors for development of subsequent metastases in localized osteosarcoma: a systematic review and identification of literature gaps. Sarcoma 2020:7431549. https://doi.org/10.1155/2020/7431549
Hung GY, Yen HJ, Yen CC, Chen WM, Chen PC, Wu HT, Chiou HJ, Chang WH, Hsu HE (2015) Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival. Ann Surg Oncol 22:1080–1087. https://doi.org/10.1245/s10434-014-4154-z
Wang J, Liu X, Yang Y, Yang R, Tang X, Yan T, Guo W (2021) Pulmonary metastasis of giant cell tumour: a retrospective study of three hundred and ten cases. Int Orthop 45:769–778. https://doi.org/10.1007/s00264-020-04907-0
Funding
This work was supported by the grant from the National Natural Science Foundation of China (82103223).
Author information
Authors and Affiliations
Contributions
Study design: Wei Guo. Data acquisition: Zhenyu Cai, Jie Xu, and Xin Sun. Analysis and interpretation of data: Zhenyu Cai, Ranxin Zhang, Lu Xie, Jichuan Wang. Drafting and critical revision: Zhenyu Cai, Jie Xu, Xiaodong Tang, Rongli Yang, and Wei Guo.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Each author certifies that the study had obtained the approval from institutional review board of People’s Hospital, Peking University. The investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in such type of study was obtained at admission. No specific IRB certification is needed for retrospective view of clinical cases at our institution. If further certificate is needed, we would like to provide at any time.
Consent for publication
Since our institution is a university-affiliated hospital, all the inpatient patients need to sign a consent at admission, indicating their information; sample or tissue may be used for educational, research purpose. For a retrospective study, no specific consent is needed for data collection and publication according to regulation at the authors’ institutional.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Level of evidence: III, Prognostic study
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cai, Z., Xu, J., Sun, X. et al. How to confront the high prevalence of pulmonary micro nodules (PMNs) in osteosarcoma patients?. International Orthopaedics (SICOT) 46, 2425–2436 (2022). https://doi.org/10.1007/s00264-022-05534-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-022-05534-7